| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 8.772 | 47.248 | 50.710 | 58.948 |
| Total Income - EUR | - | - | - | - | - | - | 8.772 | 47.323 | 50.710 | 58.948 |
| Total Expenses - EUR | - | - | - | - | - | - | 379 | 859 | 9.781 | 10.773 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 8.393 | 46.464 | 40.929 | 48.175 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 8.137 | 45.297 | 40.432 | 46.442 |
| Employees | - | - | - | - | - | - | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Globit Lab Sequence S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 2.138 | 969 | 0 |
| Current Assets | - | - | - | - | - | - | 8.454 | 43.529 | 40.987 | 47.651 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 8.254 | 36.409 | 24.264 | 42.119 |
| Cash | - | - | - | - | - | - | 200 | 7.120 | 16.723 | 5.532 |
| Shareholders Funds | - | - | - | - | - | - | 8.177 | 45.345 | 40.480 | 46.490 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 277 | 322 | 1.500 | 1.161 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6210 - 6210" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Globit Lab Sequence S.r.l.